{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:04:57Z","timestamp":1794740697418,"version":"4.9.1"},"reference-count":142,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["81470252"],"award-info":[{"award-number":["81470252"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Idiopathic pulmonary fibrosis (IPF) is a devastating disease of unknown etiology with limited treatment options. The role of the immune system in IPF has received increasing attention. Uncontrolled immune responses drive the onset and progression of IPF. This article provides an overview of the role of innate immune cells (including macrophages, neutrophils, mast cells, eosinophils, dendritic cells, nature killer cells, nature kill cells and \u03b3\u03b4 T cells) and adaptive immune cells (including Th1 cells, Th2 cells, Th9 cells, Th17 cells, Th22 cells, cytotoxic T cells, B lymphocytes and Treg cells) in IPF. In addition, we review the current status of pharmacological treatments for IPF and new developments in immunotherapy. A deeper comprehension of the immune system\u2019s function in IPF may contribute to the development of targeted immunomodulatory therapies that can alter the course of the disease.<\/jats:p>","DOI":"10.3390\/medicina59111984","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T02:10:43Z","timestamp":1699841443000},"page":"1984","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis"],"prefix":"10.3390","volume":"59","author":[{"given":"Yahan","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"},{"name":"The Center for Biomedical Research, National Health Committee (NHC) Key Laboratory of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixiang","family":"Lan","sequence":"additional","affiliation":[{"name":"Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"},{"name":"Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"},{"name":"The Center for Biomedical Research, National Health Committee (NHC) Key Laboratory of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Barratt, S.L., Creamer, A., Hayton, C., and Chaudhuri, N. (2018). Idiopathic Pulmonary Fibrosis (IPF): An Overview. J. Clin. Med., 7.","DOI":"10.3390\/jcm7080201"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1513\/AnnalsATS.201412-553OC","article-title":"Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older","volume":"12","author":"Collard","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.00185114","article-title":"Global incidence and mortality of idiopathic pulmonary fibrosis: A systematic review","volume":"46","author":"Hutchinson","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","article-title":"Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis","volume":"17","author":"Moss","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1499-3872(14)60024-2","article-title":"Inflammatory response of macrophages in infection","volume":"13","author":"Zhang","year":"2014","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2017.09.002","article-title":"Macrophage polarization and allergic asthma","volume":"191","author":"Saradna","year":"2018","journal-title":"Transl. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/path.1667","article-title":"C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases","volume":"204","author":"Okuma","year":"2004","journal-title":"J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI29919","article-title":"Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites","volume":"117","author":"Tsou","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1165\/rcmb.2015-0020TR","article-title":"Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis","volume":"53","author":"Craig","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"G723","DOI":"10.1152\/ajpgi.00414.2010","article-title":"Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages","volume":"300","author":"Barron","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"F477","DOI":"10.1152\/ajprenal.00624.2012","article-title":"Macrophage-specific deletion of transforming growth factor-\u03b21 does not prevent renal fibrosis after severe ischemia-reperfusion or obstructive injury","volume":"305","author":"Huen","year":"2013","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imm.12910","article-title":"Implications of macrophage polarization in autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/ajt.14543","article-title":"Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model","volume":"18","author":"Zhao","year":"2018","journal-title":"Am. J. Transpl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12931-018-0864-2","article-title":"Macrophages: Friend or foe in idiopathic pulmonary fibrosis?","volume":"19","author":"Zhang","year":"2018","journal-title":"Respir. Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cheng, P., Li, S., and Chen, H. (2021). Macrophages in Lung Injury, Repair, and Fibrosis. Cells, 10.","DOI":"10.3390\/cells10020436"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/mt.2016.36","article-title":"Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production","volume":"24","author":"Yao","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.173.3.2099","article-title":"Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-\u03b2-Mediated Pulmonary Fibrosis1","volume":"173","author":"Bonniaud","year":"2004","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","article-title":"Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis","volume":"54","author":"Morse","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41590-023-01551-9","article-title":"Immunology of human fibrosis","volume":"24","author":"Bhattacharya","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"eaba1972","DOI":"10.1126\/sciadv.aba1972","article-title":"Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis","volume":"6","author":"Habermann","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.3A0313-136RRR","article-title":"Pdcd4 modulates markers of macrophage alternative activation and airway remodeling in antigen-induced pulmonary inflammation","volume":"96","author":"Zhong","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cai, Z.-H., Tian, Y.-G., Li, J.-Z., Zhao, P., Li, J.-S., Mei, X., and Bai, Y.-P. (2022). Peimine ameliorates pulmonary fibrosis via the inhibition of M2-type macrophage polarization through the suppression of P38\/Akt\/STAT6 signals. Biosci. Rep., 42.","DOI":"10.1042\/BSR20220986"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.1038\/ncomms9523","article-title":"miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program","volume":"6","author":"Su","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Inui, N., Sakai, S., and Kitagawa, M. (2021). Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-\u03b2 and the Ubiquitin-Proteasome Pathway. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116107"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"107823","DOI":"10.1016\/j.intimp.2021.107823","article-title":"Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes","volume":"97","author":"Arabpour","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1165\/rcmb.2016-0121TR","article-title":"Immune Mechanisms in Pulmonary Fibrosis","volume":"55","author":"Kolahian","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kruger, P., Saffarzadeh, M., Weber, A.N.R., Rieber, N., Radsak, M., von Bernuth, H., Benarafa, C., Roos, D., Skokowa, J., and Hartl, D. (2015). Neutrophils: Between host defence, immune modulation, and tissue injury. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004651"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Voynow, J.A., and Shinbashi, M. (2021). Neutrophil Elastase and Chronic Lung Disease. Biomolecules, 11.","DOI":"10.3390\/biom11081065"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2353\/ajpath.2007.060352","article-title":"Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis","volume":"170","author":"Chua","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"104591","DOI":"10.1016\/j.phrs.2019.104591","article-title":"Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis","volume":"152","author":"Mahalanobish","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Prieto, E., Gonz\u00e1lez-L\u00f3pez, A., Cabrera, S., Astudillo, A., Guti\u00e9rrez-Fern\u00e1ndez, A., Fanjul-Fernandez, M., Batalla-Sol\u00eds, E., Puente, X.S., Fueyo, A., and L\u00f3pez-Ot\u00edn, C. (2010). Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013242"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3349\/ymj.2009.50.1.68","article-title":"Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis","volume":"50","author":"Kim","year":"2009","journal-title":"Yonsei Med. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/rmed.2003.1493","article-title":"Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects","volume":"97","author":"Beeh","year":"2003","journal-title":"Respir. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Saffarzadeh, M., Juenemann, C., Queisser, M.A., Lochnit, G., Barreto, G., Galuska, S.P., Lohmeyer, J., and Preissner, K.T. (2012). Neutrophil extracellular traps directly induce epithelial and endothelial cell death: A predominant role of histones. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032366"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fimmu.2016.00302","article-title":"New Insights into Neutrophil Extracellular Traps: Mechanisms of Formation and Role in Inflammation","volume":"7","author":"Yang","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1189\/jlb.5BT0615-234R","article-title":"At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases","volume":"99","author":"Barnado","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.20160530","article-title":"Peptidylarginine deiminase 4 promotes age-related organ fibrosis","volume":"214","author":"Martinod","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1152\/physrev.1997.77.4.1033","article-title":"Mast cells","volume":"77","author":"Metcalfe","year":"1997","journal-title":"Physiol. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trsl.2016.02.011","article-title":"Emerging concepts: Mast cell involvement in allergic diseases","volume":"174","author":"Modena","year":"2016","journal-title":"Transl. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.humpath.2017.01.007","article-title":"Transforming growth factor \u03b2- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow","volume":"62","author":"Nakayama","year":"2017","journal-title":"Hum. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/lrb.2016.0010","article-title":"Pathological Changes of Lymphedematous Skin: Increased Mast Cells, Related Proteases, and Activated Transforming Growth Factor-\u03b21","volume":"14","author":"Di","year":"2016","journal-title":"Lymphat. Res. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/abd1806-4841.20165077","article-title":"Histochemical and immunohistochemical differences between solitary oral fibroma and fibrous papule of the face","volume":"91","author":"Henriques","year":"2016","journal-title":"Bras. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chen, L., Schrementi, M.E., Ranzer, M.J., Wilgus, T.A., and DiPietro, L.A. (2014). Blockade of mast cell activation reduces cutaneous scar formation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085226"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"275172","DOI":"10.1155\/2013\/275172","article-title":"Influence of mast cells in drug-induced gingival overgrowth","volume":"2013","author":"Subramani","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/exd.12752","article-title":"Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin","volume":"24","author":"Ohashi","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_52","first-page":"3596","article-title":"Mast cell chymase in keloid induces profibrotic response via transforming growth factor-\u03b21\/Smad activation in keloid fibroblasts","volume":"7","author":"Dong","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_53","first-page":"174","article-title":"Are mast cells instrumental for fibrotic diseases?","volume":"4","author":"Rapley","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.ajpath.2013.02.013","article-title":"Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and the PAR-2\/PKC-\u03b1\/Raf-1\/p44\/42 signaling pathway","volume":"182","author":"Wygrecka","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1465-9921-12-139","article-title":"Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis","volume":"12","author":"Andersson","year":"2011","journal-title":"Respir. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/dna.2013.2005","article-title":"Mast cells: A pivotal role in pulmonary fibrosis","volume":"32","author":"Veerappan","year":"2013","journal-title":"DNA Cell Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2020.09.002","article-title":"Eosinophils: Cells known for over 140 years with broad and new functions","volume":"70","author":"Aoki","year":"2021","journal-title":"Allergol. Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1183\/09031936.98.11051009","article-title":"Eosinophil chemotactic activity in bronchoalveolar lavage from idiopathic pulmonary fibrosis is dependent on cytokine priming of eosinophils","volume":"11","author":"Boomars","year":"1998","journal-title":"Eur. Respir. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1183\/09031936.00.16595900","article-title":"Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bronchoalveolar lavage fluid in interstitial lung disease","volume":"16","author":"Taniguchi","year":"2000","journal-title":"Eur. Respir. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pupt.2017.05.007","article-title":"IL-13 and idiopathic pulmonary fibrosis: Possible links and new therapeutic strategies","volume":"45","author":"Passalacqua","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12931-016-0400-1","article-title":"Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis","volume":"17","author":"Kakugawa","year":"2016","journal-title":"Respir. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1378\/chest.92.1.51","article-title":"Prognostic role of eosinophils in pulmonary fibrosis","volume":"92","author":"Peterson","year":"1987","journal-title":"Chest"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/thx.50.10.1087","article-title":"Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis","volume":"50","author":"Boomars","year":"1995","journal-title":"Thorax"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.immuni.2014.04.016","article-title":"Development and function of dendritic cell subsets","volume":"40","author":"Mildner","year":"2014","journal-title":"Immunity"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: An update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3389\/fimmu.2018.02482","article-title":"Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update","volume":"9","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.4049\/jimmunol.176.10.5735","article-title":"Cutting edge: Nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis","volume":"176","author":"Uzunhan","year":"2006","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1165\/rcmb.2017-0051PS","article-title":"Dendritic Cell Trafficking and Function in Rare Lung Diseases","volume":"57","author":"Liu","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1164\/rccm.200609-1347OC","article-title":"Dendritic cells accumulate in human fibrotic interstitial lung disease","volume":"176","author":"Uzunhan","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.4049\/jimmunol.1900473","article-title":"TNF-Induced Interstitial Lung Disease in a Murine Arthritis Model: Accumulation of Activated Monocytes, Conventional Dendritic Cells, and CD21+\/CD23\u2212 B Cell Follicles Is Prevented with Anti-TNF Therapy","volume":"203","author":"Wu","year":"2019","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2276","article-title":"Evolutionary struggles between NK cells and viruses","volume":"8","author":"Lanier","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","article-title":"Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC","volume":"45","author":"Melhem","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2567.2009.03167.x","article-title":"Natural killer cells in infection and inflammation of the lung","volume":"128","author":"Culley","year":"2009","journal-title":"Immunology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1172\/JCI16861","article-title":"Regulation of pulmonary fibrosis by chemokine receptor CXCR3","volume":"114","author":"Jiang","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/ejh.13170","article-title":"NKT cells\u2014New players in CAR cell immunotherapy?","volume":"101","author":"Kriegsmann","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0002-9440(10)61211-4","article-title":"Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma","volume":"167","author":"Kim","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_77","first-page":"1159","article-title":"Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells","volume":"21","author":"Wang","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.trsl.2018.08.005","article-title":"The role of gamma delta T lymphocytes in breast cancer: A review","volume":"203","author":"Morrow","year":"2019","journal-title":"Transl. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41392-023-01377-9","article-title":"Activation of immune signals during organ transplantation","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_80","first-page":"1186","article-title":"Gamma delta T cells in peripheral blood and in bronchoalveolar lavage fluid from patients with sarcoidosis and idiopathic pulmonary fibrosis","volume":"33","author":"Utsumi","year":"1995","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/cei.12802","article-title":"The regulatory role of interferon-\u03b3 producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosis","volume":"185","author":"Segawa","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1084\/jem.20100061","article-title":"\u03b3\u03b4 T cells protect against lung fibrosis via IL-22","volume":"207","author":"Simonian","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ajpath.2010.11.055","article-title":"\u03b3\u03b4 T cells attenuate bleomycin-induced fibrosis through the production of CXCL10","volume":"178","author":"Pociask","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni0603-503","article-title":"TH1-TH2: A procrustean paradigm","volume":"4","author":"Gor","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1398-9995.1992.tb00662.x","article-title":"Human Th1 and Th2 lymphocytes: Their role in the pathophysiology of atopy","volume":"47","year":"1992","journal-title":"Allergy"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/clim.2001.5008","article-title":"Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment","volume":"99","author":"Sime","year":"2001","journal-title":"Clin. Immunol."},{"key":"ref_87","first-page":"S63","article-title":"Cytokine phenotypes serve as a paradigms for experimental immune-mediated lung diseases and remodeling","volume":"29","author":"Kunkel","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1378\/chest.120.1_suppl.S5","article-title":"Type 1\/type 2 cytokine paradigm and the progression of pulmonary fibrosis","volume":"120","author":"Lukacs","year":"2001","journal-title":"Chest"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.1378\/chest.120.1_suppl.S77-a","article-title":"Mechanisms of pulmonary fibrosis: Conference summary","volume":"120","author":"Strieter","year":"2001","journal-title":"Chest"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1165\/ajrcmb.24.5.4064","article-title":"Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin","volume":"24","author":"Chen","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.4049\/jimmunol.171.5.2684","article-title":"Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells","volume":"171","author":"Jakubzick","year":"2003","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.4049\/jimmunol.170.4.2083","article-title":"Dual roles of IL-4 in lung injury and fibrosis","volume":"170","author":"Huaux","year":"2003","journal-title":"J. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1)","volume":"194","author":"Lee","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1165\/rcmb.2002-0009OC","article-title":"Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis","volume":"27","author":"Belperio","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1165\/rcmb.2003-0299OC","article-title":"Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice","volume":"31","author":"Barbarin","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1084\/jem.20170928","article-title":"Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation","volume":"215","author":"Xiao","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2013.10.004","article-title":"Th9 cells, new players in adaptive immunity","volume":"35","author":"Schmitt","year":"2014","journal-title":"Trends Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","article-title":"Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells","volume":"33","author":"Staudt","year":"2010","journal-title":"Immunity"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1165\/rcmb.2017-0287OC","article-title":"IL-9 Blockade Suppresses Silica-induced Lung Inflammation and Fibrosis in Mice","volume":"60","author":"Sugimoto","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1165\/rcmb.2006-0397OC","article-title":"Profibrotic effect of IL-9 overexpression in a model of airway remodeling","volume":"37","author":"Heymans","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.intimp.2019.03.061","article-title":"Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib","volume":"72","author":"Bellamri","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"688066","DOI":"10.3389\/fimmu.2021.688066","article-title":"Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.4049\/jimmunol.1601480","article-title":"Th22 Cells Form a Distinct Th Lineage from Th17 Cells In Vitro with Unique Transcriptional Properties and Tbet-Dependent Th1 Plasticity","volume":"198","author":"Plank","year":"2017","journal-title":"J. Immunol."},{"key":"ref_105","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Kim, Y., Lee, J., Kim, J., Choi, C.W., Hwang, Y.-I., Kang, J.S., and Lee, W.J. (2017). The pathogenic role of interleukin-22 and its receptor during UVB-induced skin inflammation. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178567"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.4049\/jimmunol.1600126","article-title":"Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway","volume":"198","author":"Lou","year":"2017","journal-title":"J. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-9255-4-14","article-title":"CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis","volume":"4","author":"Papiris","year":"2007","journal-title":"J. Inflamm."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.4049\/jimmunol.1500777","article-title":"IL-21 Promotes Pulmonary Fibrosis through the Induction of Profibrotic CD8+ T Cells","volume":"195","author":"Brodeur","year":"2015","journal-title":"J. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"O\u2019Flaherty, B.M., Matar, C.G., Wakeman, B.S., Garcia, A., Wilke, C.A., Courtney, C.L., Moore, B.B., and Speck, S.H. (2015). CD8+ T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient Mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135719"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: How they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.1203476","article-title":"Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients","volume":"191","author":"Xue","year":"2013","journal-title":"J. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2101469","DOI":"10.1183\/13993003.01469-2021","article-title":"Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis","volume":"60","author":"Miles","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.rmed.2012.10.018","article-title":"Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis","volume":"107","author":"Lee","year":"2013","journal-title":"Respir. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.08.003","article-title":"B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis","volume":"56","author":"Gombault","year":"2015","journal-title":"J. Autoimmun."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/JIR.S40673","article-title":"Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis","volume":"6","author":"Todd","year":"2013","journal-title":"J. Inflamm. Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.celrep.2018.06.052","article-title":"OX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms","volume":"24","author":"Zhang","year":"2018","journal-title":"Cell Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-019-00741-8","article-title":"Treg cells in autoimmunity: From identification to Treg-based therapies","volume":"41","author":"Scheinecker","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1038\/ncomms9266","article-title":"GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation","volume":"6","author":"Xiao","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coi.2020.07.004","article-title":"New Treg cell-based therapies of autoimmune diseases: Towards antigen-specific immune suppression","volume":"67","author":"Mikami","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"106443","DOI":"10.1016\/j.intimp.2020.106443","article-title":"Regulatory T cells are a double-edged sword in pulmonary fibrosis","volume":"84","author":"Wang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cyto.2013.12.003","article-title":"Peripheral depletion of NK cells and imbalance of the Treg\/Th17 axis in idiopathic pulmonary fibrosis patients","volume":"66","author":"Galati","year":"2014","journal-title":"Cytokine"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Lee, G.R. (2018). The Balance of Th17 versus Treg Cells in Autoimmunity. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030730"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"108620","DOI":"10.1016\/j.clim.2020.108620","article-title":"Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING\/ILC2 axis","volume":"222","author":"Domvri","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.imbio.2012.05.020","article-title":"Differential role of regulatory T cells in early and late stages of pulmonary fibrosis","volume":"218","author":"Toda","year":"2013","journal-title":"Immunobiology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"170057","DOI":"10.1183\/16000617.0057-2017","article-title":"Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis","volume":"26","author":"Lancaster","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1183\/09031936.00073012","article-title":"The pathogenesis of pulmonary fibrosis: A moving target","volume":"41","author":"Wuyts","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(02)01758-2","article-title":"A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level","volume":"446","author":"Nakazato","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Shi, Q., Liu, X., Bai, Y., Cui, C., Li, J., Li, Y., Hu, S., and Wei, Y. (2011). In vitro effects of pirfenidone on cardiac fibroblasts: Proliferation, myofibroblast differentiation, migration and cytokine secretion. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028134"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1165\/rcmb.2005-0452OC","article-title":"Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge","volume":"35","author":"Hirano","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/rcmb.2019-0328TR","article-title":"Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease","volume":"62","author":"Ruwanpura","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12931-014-0157-3","article-title":"Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis","volume":"15","author":"Hostettler","year":"2014","journal-title":"Respir. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"L1025","DOI":"10.1152\/ajplung.00526.2018","article-title":"Epidermal growth factor receptor paracrine upregulation in idiopathic pulmonary fibrosis fibroblasts is blocked by nintedanib","volume":"316","author":"Brook","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.resinv.2020.01.003","article-title":"Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-\u03b2\/Smad pathway","volume":"58","author":"Ihara","year":"2020","journal-title":"Respir. Investig."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fphar.2019.00532","article-title":"Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy","volume":"10","author":"Kasam","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1165\/rcmb.2014-0445OC","article-title":"Novel Mechanisms for the Antifibrotic Action of Nintedanib","volume":"54","author":"Rangarajan","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/thoraxjnl-2019-214000","article-title":"Inhibition of mast cells: A novel mechanism by which nintedanib may elicit anti-fibrotic effects","volume":"75","author":"Miranda","year":"2020","journal-title":"Thorax"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Chen, W.-C., Chen, N.-J., Chen, H.-P., Yu, W.-K., Su, V.Y.-F., Chen, H., Wu, H.-H., and Yang, K.-Y. (2020). Nintedanib Reduces Neutrophil Chemotaxis via Activating GRK2 in Bleomycin-Induced Pulmonary Fibrosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134735"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/11\/1984\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:21:12Z","timestamp":1760131272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/11\/1984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":142,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["medicina59111984"],"URL":"https:\/\/doi.org\/10.3390\/medicina59111984","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]}}}